VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: biowa who wrote (6711)	6/7/1999 11:51:00 PM
From: biowa	Read Replies (1) of 9719

V1, What I really like about Cubist is it's late-stage antibiotic candidate, daptomycin. In Phase III trials, this molecule has some really undervalued potential, though it is only intravenous. Potentially, it could be the standard of care for empiric treatment of Gram positive infections by early in the next decade. biowa

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next